BRCA2 and neoplasm: Multiple small molecules have been reported that inhibit HR by directly blocking RAD51 activity or disrupting its interaction with BRCA2, thereby preventing RAD51 filament assembly and inducing synthetic‐lethal cell death in tumours with heightened dependence on HR.